Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,049 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phenotypic variability in ARCA2 and identification of a core ataxic phenotype with slow progression.
Mignot C, Apartis E, Durr A, Marques Lourenço C, Charles P, Devos D, Moreau C, de Lonlay P, Drouot N, Burglen L, Kempf N, Nourisson E, Chantot-Bastaraud S, Lebre AS, Rio M, Chaix Y, Bieth E, Roze E, Bonnet I, Canaple S, Rastel C, Brice A, Rötig A, Desguerre I, Tranchant C, Koenig M, Anheim M. Mignot C, et al. Among authors: moreau c. Orphanet J Rare Dis. 2013 Oct 28;8:173. doi: 10.1186/1750-1172-8-173. Orphanet J Rare Dis. 2013. PMID: 24164873 Free PMC article.
Levodopa for Parkinson's disease.
Devos D, Moreau C, Destée A. Devos D, et al. Among authors: moreau c. N Engl J Med. 2009 Feb 26;360(9):935-6; author reply 936. doi: 10.1056/NEJMc082718. N Engl J Med. 2009. PMID: 19246370 No abstract available.
Methylphenidate : a treatment for Parkinson's disease?
Devos D, Moreau C, Delval A, Dujardin K, Defebvre L, Bordet R. Devos D, et al. Among authors: moreau c. CNS Drugs. 2013 Jan;27(1):1-14. doi: 10.1007/s40263-012-0017-y. CNS Drugs. 2013. PMID: 23160937
New pharmacological options for treating advanced Parkinson's disease.
Devos D, Moreau C, Dujardin K, Cabantchik I, Defebvre L, Bordet R. Devos D, et al. Among authors: moreau c. Clin Ther. 2013 Oct;35(10):1640-52. doi: 10.1016/j.clinthera.2013.08.011. Epub 2013 Sep 5. Clin Ther. 2013. PMID: 24011636 Free article. Review.
TMEM240 mutations cause spinocerebellar ataxia 21 with mental retardation and severe cognitive impairment.
Delplanque J, Devos D, Huin V, Genet A, Sand O, Moreau C, Goizet C, Charles P, Anheim M, Monin ML, Buée L, Destée A, Grolez G, Delmaire C, Dujardin K, Dellacherie D, Brice A, Stevanin G, Strubi-Vuillaume I, Dürr A, Sablonnière B. Delplanque J, et al. Among authors: moreau c. Brain. 2014 Oct;137(Pt 10):2657-63. doi: 10.1093/brain/awu202. Epub 2014 Jul 28. Brain. 2014. PMID: 25070513
Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.
Moreau C, Meguig S, Corvol JC, Labreuche J, Vasseur F, Duhamel A, Delval A, Bardyn T, Devedjian JC, Rouaix N, Petyt G, Brefel-Courbon C, Ory-Magne F, Guehl D, Eusebio A, Fraix V, Saulnier PJ, Lagha-Boukbiza O, Durif F, Faighel M, Giordana C, Drapier S, Maltête D, Tranchant C, Houeto JL, Debû B, Azulay JP, Tison F, Destée A, Vidailhet M, Rascol O, Dujardin K, Defebvre L, Bordet R, Sablonnière B, Devos D; Parkgait-II Study Group. Moreau C, et al. Brain. 2015 May;138(Pt 5):1271-83. doi: 10.1093/brain/awv063. Epub 2015 Mar 23. Brain. 2015. PMID: 25805645 Free PMC article. Clinical Trial.
Opicapone for motor fluctuations in Parkinson's disease.
Devos D, Moreau C. Devos D, et al. Among authors: moreau c. Lancet Neurol. 2016 Feb;15(2):127-128. doi: 10.1016/S1474-4422(15)00346-4. Epub 2015 Dec 23. Lancet Neurol. 2016. PMID: 26725545 No abstract available.
1,049 results